Table 2: Demographic and clinical characteristics of patients with and without acute GVHD.

CaseAgeRecipient
gender
Doner
gender
Underlying
disease
Donor
type
PretreatmentClinically affected
aGVHD organ
aGVHD
grade

148MFAMLRelatedBU + CYSkin, mouth, gastrointestinal tractIV
236MFAMLRelatedBU + CY0
325MMAMLRelatedBU + CY0
447MMAMLRelatedBU + CYSkin, mouth0
553FFCMLRelatedFlud + BUGastrointestinal tractIII
614MMALLRelatedTBI + CY + ATG0
731FFAMLUnrelatedBU + CYSkinI
815MMAMLRelatedBU + CY + ATGSkin, liverII
940MMMDSRelatedBU + CY + ATGSkin, mouth, gastrointestinal tractIV
1022MMALLRelatedTBI + CY + ATGSkin, mouth, liver, gastrointestinal tractIII
1122MMMDSUnrelatedBU + CY + ATGSkin, mouth, gastrointestinal tractIV
1244FFAMLUnrelatedBU + CY + ATGGastrointestinal tractII
1328MMALLUnrelatedTBI + CY + ATG0
1428MMALLRelatedTBI + CY0
1647FFCMLRelatedBU + CYSkin, liver, gastrointestinal tractII
1743MMMDSRelatedBU + CY + ATGGastrointestinal tractII
1844MFAMLRelatedBU + CYLiver, gastrointestinal tractIII
1949FFALLUnrelatedBU + CY + ATGGastrointestinal tractII
2215MMALLUnrelatedBU + CY + ATGSkinI
3023MMALLRelatedFlud + BUGastrointestinal tractII
3316MFMDSRelatedBU + CY + ATGGastrointestinal tractI
3643MMAMLUnrelatedBU + CY + ATGSkinI
3927FFCMLUnrelatedBU + CYSkin, mouthI
4045MMMDSRelatedBU + CYSkinI

M: male; F: female; AML: acute myelogenous leukemia; CML: chronic myelogenous leukemia; MDS: myelodysplastic syndrome; ALL: acute lymophoblastic leukemia; TBI: total body irradiation; BU: busulfan; CY: cyclophosphamide; Flud: fludarabine; ATG: rabbit antithymocyte globulin.